SOCIAL SCIENCES & HUMANITIES
Exploring human experience
Up to 30% off essentials books & eBooks!

Fundamentals and Future Trends of 3D Printing in Drug Delivery provides readers with all needed information for their journey from ideation to approval of innovative drug delivery… Read more
SOCIAL SCIENCES & HUMANITIES
Up to 30% off essentials books & eBooks!
Fundamentals and Future Trends of 3D Printing in Drug Delivery provides readers with all needed information for their journey from ideation to approval of innovative drug delivery devices produced through additive manufacturing.
This book provides an in-depth discussion on key factors affecting the printing process such as different printer technologies, materials selection, resolutions, temperatures and speeds. Dedicated chapters include specific drug delivery devices in the form of oral solid dosage, implants, catheters and vascular grafts, and microneedles. The prospects of 3D printing associated with personalized medicine are covered in a full chapter.
Fundamentals and Future Trends of 3D Printing in Drug Delivery is the perfect reference for any researcher or professional embarking on a 3D printing process for drug delivery devices. The regulatory aspects included are of particular interest to companies entering this promising market.
Researchers in Industry and Academia working in drug delivery and medical implants, in general, and specifically using additive manufacturing technologies. Undergraduate and Postgraduate (e.g., Masters, Ph.D.) students in Pharmacy, Pharmaceutical Sciences, and Pharmaceutical Biotechnology. Regulatory bodies. Pharmaceutical, biopharmaceutical, additive manufacturing, and biofabrication industries. The book can be used from most pharmacy, pharmaceutical sciences, and pharmaceutical technologies courses for undergraduate students and from a variety of Master courses worldwide (e.g., Additive Manufacturing, Industrial Pharmaceutics, Drug Delivery, and Biofabrication)
DL
Professor Dimitrios A. Lamprou (Ph.D. MBA) is the Chair of Biofabrication and Advanced Manufacturing, the Director of Internationalisation, and the Director at MSc Industrial Pharmaceutics at Queen's University Belfast. He is also the Chair at United Kingdom and Ireland Controlled Release Society (UKICRS) and Visiting Professor in several International Institutions. Dimitrios, is the author of more than 170 peer-reviewed publications, has over 450 conference abstracts, and has given over 200 Invited Talks in institutions and conferences across the world. Dimitrios, has also been named in the Stanford University's list of World's Top 2% Scientists, for several consecutive years, for his research in Pharmaceutics and Biomedical Engineering.
DF